RNA therapies are emerging as a promising treatment for cancer, but some types
of the disease don’t respond well to it. Now, scientists at Tel Aviv University have
demonstrated a way to use RNA drugs to treat multiple myeloma, a hard-to-reach
cancer that forms deep in bone tissue.
Multiple myeloma is a cancer that affects a patient’s plasma cells. As these important
immune cells become cancerous, they accumulate in the bone marrow, causing pain
and immune issues. While the disease can be managed, it can’t currently be cured,
thanks largely to the difficulty in getting drugs to the tumors inside the patient’s bones.
